rs886058642
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000094.4(COL7A1):c.1637-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.000000684 in 1,460,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000094.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL7A1 | ENST00000681320.1 | c.1637-1G>A | splice_acceptor_variant, intron_variant | Intron 13 of 118 | NM_000094.4 | ENSP00000506558.1 | ||||
COL7A1 | ENST00000328333.12 | c.1637-1G>A | splice_acceptor_variant, intron_variant | Intron 12 of 117 | 1 | ENSP00000332371.8 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1460942Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 726780
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 10504458, 25525159, 12813757) -
This sequence change affects an acceptor splice site in intron 12 of the COL7A1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with ‚Äãclinical features of autosomal recessive epidermolysis bullosa (PMID: 10504458, 12813757). ClinVar contains an entry for this variant (Variation ID: 345869). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Recessive dystrophic epidermolysis bullosa;C0268371:Dominant dystrophic epidermolysis bullosa with absence of skin;C0432321:Pretibial dystrophic epidermolysis bullosa;C0432322:Generalized dominant dystrophic epidermolysis bullosa;C1275114:Epidermolysis bullosa pruriginosa;C1843761:Nonsyndromic congenital nail disorder 8;C1851573:Transient bullous dermolysis of the newborn Pathogenic:1
- -
Epidermolysis bullosa dystrophica Pathogenic:1
The COL7A1 c.1637-1G>A variant occurs in a canonical splice site (acceptor) and is therefore predicted to disrupt or distort the normal gene product. The c.1637-1G>A variant has been reported in three individuals with dystrophic epidermolysis bullosa, including in one in a homozygous state, in one in a compound heterozygous state, and in at least one individual of unknown zygosity (Whittock et al. 1999; Pfendner et al. 2003; Varki et al. 2007). Control data are unavailable for the c.1637-1G>A variant, which is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. RT-PCR analysis demonstrated that the variant results in truncation of the COL7A1 protein (Whittock et al. 1999). Based on the evidence and the potential impact of splice acceptor variants, the c.1637-1G>A variant is classified as likely pathogenic for dystrophic epidermolysis bullosa. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
COL7A1-related disorder Pathogenic:1
The COL7A1 c.1637-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant along with a second variant in this gene was reported in an individual with dystrophic epidermolysis bullosa (Whittock et al 1999. PubMed ID: 10504458). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice acceptor site in COL7A1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at